BR0014380A - Usos de modafinil e seus enanciÈmeros d/l - Google Patents

Usos de modafinil e seus enanciÈmeros d/l

Info

Publication number
BR0014380A
BR0014380A BR0014380-4A BR0014380A BR0014380A BR 0014380 A BR0014380 A BR 0014380A BR 0014380 A BR0014380 A BR 0014380A BR 0014380 A BR0014380 A BR 0014380A
Authority
BR
Brazil
Prior art keywords
medicine
modafinil
mammals
enhancing
new uses
Prior art date
Application number
BR0014380-4A
Other languages
English (en)
Inventor
Junchang Fu
Original Assignee
Junchang Fu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Junchang Fu filed Critical Junchang Fu
Publication of BR0014380A publication Critical patent/BR0014380A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Valve Device For Special Equipments (AREA)

Abstract

"USOS DE MODAFINIL E SEUS ENANCIÈMEROS D/L". Esta invenção refere-se a novos usos de Modafinil e seus enantiómeros D/L, particularmente a novos usos no campo de preparação farmacêutica. Esta invenção provê novos usos de Modafinil e seus enantiómeros D/L na preparação do remédio para aumentar e melhorar a quantidade e qualidade de espermatozóides normais em mamíferos machos, o remédio para aumentar a capacidade de engravidamento em mamíferos fêmeas, o remédio para o tratamento de infertilidade, subfertilidade e disfunção sexual em mamíferos machos e fêmeas, e o remédio para aumentar a função sexual em mamíferos.
BR0014380-4A 1999-09-29 2000-04-12 Usos de modafinil e seus enanciÈmeros d/l BR0014380A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN99119726A CN1249932A (zh) 1999-09-29 1999-09-29 一种莫达芬尼及其光学对映体l及d异构体的新用途
PCT/CN2000/000087 WO2001022961A1 (fr) 1999-09-29 2000-04-12 Nouvelle application de modafinil et de son enantiomere d/l

Publications (1)

Publication Number Publication Date
BR0014380A true BR0014380A (pt) 2002-06-18

Family

ID=5281058

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014380-4A BR0014380A (pt) 1999-09-29 2000-04-12 Usos de modafinil e seus enanciÈmeros d/l

Country Status (13)

Country Link
US (2) US6348500B1 (pt)
EP (1) EP1291016B1 (pt)
JP (1) JP3883867B2 (pt)
CN (2) CN1249932A (pt)
AT (1) ATE472322T1 (pt)
AU (1) AU3954700A (pt)
BR (1) BR0014380A (pt)
CA (1) CA2385986C (pt)
DE (1) DE60044617D1 (pt)
HK (1) HK1046504A1 (pt)
RU (1) RU2241450C2 (pt)
TW (1) TWI224505B (pt)
WO (1) WO2001022961A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249932A (zh) 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
DK1309547T3 (da) * 2000-07-27 2007-05-21 Teva Pharma Krystallinsk og ren modafinil og fremgangsmåde til fremstilling af samme
HU229409B1 (en) * 2000-10-11 2013-12-30 Cephalon Compositions comprising modafinil compounds
CN101606916B (zh) * 2002-09-13 2011-02-09 赛福伦公司 莫达非尼片剂及其应用
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7553646B2 (en) * 2005-07-28 2009-06-30 University Of Iowa Research Foundation Microbial sulfoxidation and amidation of benzhdrylsulfanyl carboxylic acids and uses thereof
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
DK2056811T3 (en) 2006-08-14 2018-05-22 Neurohealing Pharmaceuticals Inc Modafinil-based treatment for premature ejaculation
US20100010092A1 (en) * 2006-12-19 2010-01-14 Arless Ltd. Use of modafinil to treat restless leg syndrome
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
CN103713120B (zh) * 2013-12-20 2015-09-23 浙江大学 基于液相芯片技术判断体液环境中细胞状态的方法
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement
RU2619330C1 (ru) * 2016-03-24 2017-05-15 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Д. Гольдберга" Средство для профилактики и лечения патозооспермии

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
CN1249932A (zh) 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途

Also Published As

Publication number Publication date
WO2001022961A1 (fr) 2001-04-05
RU2241450C2 (ru) 2004-12-10
TWI224505B (en) 2004-12-01
CN1249932A (zh) 2000-04-12
CA2385986C (en) 2008-11-18
ATE472322T1 (de) 2010-07-15
US6465519B2 (en) 2002-10-15
JP2003516932A (ja) 2003-05-20
CN1353604A (zh) 2002-06-12
CN1214786C (zh) 2005-08-17
CA2385986A1 (en) 2001-04-05
AU3954700A (en) 2001-04-30
US6348500B1 (en) 2002-02-19
US20020120010A1 (en) 2002-08-29
EP1291016A4 (en) 2004-01-14
EP1291016B1 (en) 2010-06-30
DE60044617D1 (de) 2010-08-12
HK1046504A1 (en) 2003-01-17
EP1291016A1 (en) 2003-03-12
JP3883867B2 (ja) 2007-02-21

Similar Documents

Publication Publication Date Title
BR0014380A (pt) Usos de modafinil e seus enanciÈmeros d/l
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
MY119181A (en) Aryl pyrimidine derivatives
YU30004A (sh) Upotreba flibanserina u lečenju seksualnih poremećaja
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
ATE297208T1 (de) Tablette mit verlängerter wirkstoffabgabe zur behandlung der parkinsonkrankheit
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
WO2003092580A3 (en) Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
NZ709704A (en) Protein formulations and methods of making same
GB0102687D0 (en) Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
HUP0004347A2 (hu) Vegyületek női szexuális diszfunkció kezelésére
MX348062B (es) Mutantes que degradan proteoglicanos para tratamiento del snc.
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
MY133393A (en) Phenyl xanthine derivatives
ATE308538T1 (de) Verwendung von selektiven alpha-adrenergischen rezeptorantagonisten zur behandlung sexueller störungen
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
MXPA05003718A (es) Compuestos x-nitro, sus composiciones farmaceuticas y sus usos.
HUP0402358A2 (hu) Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
NO20062883L (no) Fosfodiesterase-V-inhibitorpreparater
TW200505916A (en) 7-azaindoles and the use thereof as therapeutic agents
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
TW200503693A (en) 4-, 6- or 7-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 13A E 14A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 13A, 14A, 15A, 16A, 17A, 18A, 19A E 20A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.